BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8112548)

  • 1. [Humoral immunologic changes in inflammatory colonic diseases].
    Matos M; Capozzolo N; Golindano C; González JC; Guirola E; Ramirez R; Machado I
    G E N; 1993; 47(3):129-35. PubMed ID: 8112548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.
    Engstrom JF; Arvanitakis C; Sagawa A; Abdou NI
    Gastroenterology; 1978 Apr; 74(4):747-51. PubMed ID: 415931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological findings in whole and parotid saliva of patients with ulcerative colitis and healthy controls.
    Crama-Bohbouth G; Peña AS; Verspaget HW; vd Zon A; Biemond I; Weterman IT; Lamers CB
    Hepatogastroenterology; 1989 Aug; 36(4):185-7. PubMed ID: 2807134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and immunoglobulin levels in Ilorin Nigeria, and environ.
    Oyeyinka GO; Aiyedun BA; Erasmus RT; Adewoye HO; Adetoro OO; Adedoyin MA
    Afr J Med Med Sci; 1995 Mar; 24(1):9-16. PubMed ID: 7495207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
    Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
    Cagatay T; Bilir M; Gulbaran M; Papila C; Cagatay P
    Kobe J Med Sci; 2003; 49(5-6):99-106. PubMed ID: 15141145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of connective-tissue disease in men with testicular or penile prostheses: a preliminary study.
    Ku JH; Song YS; Jeon YS; Kim ME; Lee NK; Park YH
    Asian J Androl; 2002 Mar; 4(1):67-72. PubMed ID: 11907631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
    Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
    Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.
    Danis VA; Harries AD; Heatley RV
    Clin Exp Immunol; 1984 Apr; 56(1):159-66. PubMed ID: 6713728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of some immunological parameters in pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M; Hoppe A
    Pol Merkur Lekarski; 2004 Feb; 16(92):123-7. PubMed ID: 15176294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease].
    Barta Z; Csípö I; Antal-Szalmás P; Sipka S; Szabó G; Szegedi G
    Orv Hetil; 2001 Oct; 142(42):2303-7. PubMed ID: 11760647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating immune complexes and in vivo fixation of immunoglobulin G, A and C3 onto hepatocytes in patients with Crohn's disease (author's transl)].
    Eckhardt R; Hopf U; Hütteroth TH; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1978 Dec; 16(12):739-47. PubMed ID: 741844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
    D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
    Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement as a predictor of further miscarriage in couples with recurrent miscarriages.
    Sugiura-Ogasawara M; Nozawa K; Nakanishi T; Hattori Y; Ozaki Y
    Hum Reprod; 2006 Oct; 21(10):2711-4. PubMed ID: 16790609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.